| Income Statement |
| Operating Expenses | 8.11M |
|
| Research and Development Expense | 5.14M |
| Selling, General and Administrative Expense | 2.98M |
| Operating Income | -8.11M |
| Net Income | -7.96M |
| Net Income Common Stock | -7.96M |
| Net Income Common Stock (USD) | -7.96M |
| Consolidated Income | -7.96M |
| Earnings per Basic Share | -0.86 |
| Earnings per Basic Share (USD) | -0.86 |
| Earnings per Diluted Share | -0.86 |
| Earning Before Interest & Taxes (EBIT) | -7.96M |
| Earning Before Interest & Taxes (USD) | -7.96M |
| Weighted Average Shares | 9.26M |
| Weighted Average Shares Diluted | 9.26M |
| Balance Sheet |
| Cash and Equivalents | 7.94M |
| Cash and Equivalents (USD) | 7.94M |
| Investments | 4.98M |
| Investments Current | 4.98M |
| Current Assets | 15.11M |
| Total Assets | 15.11M |
| Current Liabilities | 4.50M |
| Total Liabilities | 4.50M |
| Accumulated Retained Earnings (Deficit) | -105.66M |
| Accumulated Other Comprehensive Income | -208.00 |
| Shareholders Equity | 10.62M |
| Shareholders Equity (USD) | 10.62M |
| Trade and Non-Trade Payables | 2.27M |
| Cash Flow |
| Net Cash Flow from Financing | 13.80K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -293.72K |
| Issuance (Purchase) of Equity Shares | 13.80K |
| Net Cash Flow from Investing | 7.71M |
| Net Cash Flow - Investment Acquisitions and Disposals | 7.71M |
| Net Cash Flow from Operations | -8.02M |
| Share Based Compensation | 349.20K |